Convalescent Plasma Versus Hyperimmune Immunoglobulins
Clin Infect Dis
.
2023 Nov 11;77(9):1356-1357.
doi: 10.1093/cid/ciad406.
Authors
Daniele Focosi
1
,
Massimo Franchini
2
,
Emanuele Nicastri
3
,
David J Sullivan
4
,
Arturo Casadevall
4
Affiliations
1
North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
2
Division of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
3
Division of Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani," Rome, Italy.
4
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
PMID:
37399022
DOI:
10.1093/cid/ciad406
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Immunoglobulins* / therapeutic use
Substances
Immunoglobulins